Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Revenue | $33,537,000 | $32,364,000 | $31,227,000 | $31,686,000 |
| % Growth | 3.6% | 3.6% | -1.4% | – |
| Cost of Goods Sold | $11,632,000 | $11,216,000 | $10,719,000 | $10,145,000 |
| Gross Profit | $21,905,000 | $21,148,000 | $20,508,000 | $21,541,000 |
| % Margin | 65.3% | 65.3% | 65.7% | 68% |
| R&D Expenses | $2,732,000 | $2,735,000 | $2,696,000 | $2,746,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10,849,000 | $10,736,000 | $10,415,000 | $10,292,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,369,000 | $2,533,000 | $1,912,000 | $2,751,000 |
| Operating Expenses | $15,950,000 | $16,004,000 | $15,023,000 | $15,789,000 |
| Operating Income | $5,955,000 | $5,144,000 | $5,485,000 | $5,752,000 |
| % Margin | 17.8% | 15.9% | 17.6% | 18.2% |
| Other Income/Exp. Net | -$327,000 | -$307,000 | -$121,000 | -$235,000 |
| Pre-Tax Income | $5,628,000 | $4,837,000 | $5,364,000 | $5,517,000 |
| Tax Expense | $936,000 | $1,133,000 | $1,580,000 | $456,000 |
| Net Income | $4,662,000 | $3,676,000 | $3,758,000 | $5,039,000 |
| % Margin | 13.9% | 11.4% | 12% | 15.9% |
| EPS | 3.63 | 2.77 | 2.83 | 3.75 |
| % Growth | 31% | -2.1% | -24.5% | – |
| EPS Diluted | 3.61 | 2.76 | 2.82 | 3.73 |
| Weighted Avg Shares Out | 1,285,600 | 1,327,700 | 1,329,800 | 1,342,400 |
| Weighted Avg Shares Out Dil | 1,289,900 | 1,330,200 | 1,332,800 | 1,351,400 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $729,000 | $719,000 | $636,000 | $553,000 |
| Depreciation & Amortization | $2,861,000 | $2,647,000 | $2,697,000 | $2,707,000 |
| EBITDA | $9,218,000 | $8,203,000 | $8,697,000 | $8,777,000 |
| % Margin | 27.5% | 25.3% | 27.9% | 27.7% |